Early value dossiers for medical technologies
The essential tool to understand the value proposition for your product and position it well with reimbursement/HTA stakeholders
Recent news and posts
2024/25 Prescribed Specialised Services Operational Tool released in England
On April 3, 2024, NHS England published the 2024/25 Prescribed Specialised Services (PSS) Operational Tool. This Tool is used as a mechanism to identify whether healthcare activity belongs to specialized services using so-called identification rules. Forty-three new service lines were introduced in multiple areas. Some examples are provided below:
- NCBPS61M Specialist cancer services (adults): head and neck cancer surgery;
- NCBPS51A Interventional oncology (adults);
- NCBPS08V MR-guided laser interstitial thermal therapy (MRgLITT) (adults);
- NCBPS58G Neurosurgery LVHC (low volume high-complexity) regional: deep brain stimulation;
- NCBPS58L Neurosurgery LVHC local: anterior lumbar fusion.
Furthermore, eight service lines were updated.
Eligible top-up rates (PSS top-up - % uplift to HRG tariff when procedure performed in the specialized center) connected to each service line are published in the NHS Payment Scheme (Annex A, 2024/25).
See the full details here.
This news is just one of about 300 market access news collected by our team in the premium subscription service Market Access Monitor every week from more than 80 organizations. Access our paid service to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news). Access is organized as an online Database and email alert formats. Contact us to get a free, three-month, no-obligation trial.